Indiana drug giant
The bill (S.B. 1) blocks tort claims, including class actions, against companies, governments, and individuals who are accused of negligently spreading the virus—a bipartisan “liability shield” similar to those enacted by many states. The bill also goes a step further to benefit the broader drug and medical supply industry by blocking liability for makers and suppliers of medicines, protective equipment, supplies, and ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.